Searched for
GLENMARK PHARMACEUTICALS UPDATE
Glenmark Pharma shares in focus after USFDA warning to Indore plantGlenmark Pharmaceuticals disclosed receiving a warning letter from the U.S. FDA for its Indore facility following a February inspection. Th...- Glenmark Q3 Results: Co reports net loss of Rs 351 cr on lower domestic salesTotal revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a ...
- Sun TV, Emami among 10 stocks with RSI trending upDiscover the significance of Relative Strength Index (RSI) in stock analysis as we explore 10 stocks that have witnessed an RSI trending up...
- Glenmark Pharma to sell 75% stake in Glenmark Life to Nirma for Rs 5,652 croreGlenmark Pharmaceuticals will sell 9,18,95,379 shares in the subsidiary at Rs 615 a share. The 75% stake sale in Glenmark Life Sciences wil...
- Glenmark Pharma, KSB, 4 other small cap stocks hit 52-week high on ThursdaySmall-cap stocks stole the spotlight today on September 21, 2023, as several companies achieved significant milestones, hitting new 52-week...
- Lupin, Glenmark Pharma, 7 BSE Healthcare stocks which hit 52-week high on WednesdayThe data was sourced from BSE at 2.50 pm, and the updates from the real-time data could come with a lag. The below data also pertains only ...
- Sun Pharma, Lupin among 9 BSE Healthcare stocks that hit new 52-week highs on ThursdayThe healthcare sector's impressive performance in the stock market highlights these companies' commitment to innovation, research, and deli...
- Jindal Steel, Glenmark Pharma, 7 other midcap stocks that hit 52-week highNotable gainers included MRF, Torrent Pharmaceuticals, Jindal Steel, Glenmark Pharma, TVS Motor Company, and more, solidifying their positi...
- Jindal Steel, TVS Motor among 9 BSE midcap stocks hit new 52-week highThe BSE MidCap index witnessed an impressive surge today as prominent companies marked new 52-week highs. Notable gainers included Ajanta P...
- Glenmark Pharma, Canara Bank among 10 midcap stocks which hit new 52-week high on MondayThe S&P BSE MidCap Index saw an impressive display of strength on July 24, 2023, with companies like Aurobindo Pharma, Canara Bank, and Gen...
- Aurobindo Pharma among 8 BSE Pharma Index stocks which surge to new 52-week highs on FridayGlenmark Life Sciences achieved a new 52-week high at Rs. 658 on July 21, 2023. As a subsidiary of Glenmark Pharma, Glenmark Life Sciences ...
- Ashok Leyland, Samvardhana Motherson among 8 BSE midcap stocks which hit new 52-week highAfter its Q1 results, Ashok Leyland achieved a new 52-week high at Rs. 183.25 on July 21, 2023. As a major player in the automotive industr...
- P&G, Canara Bank among 7 midcap stocks which hit new 52-week highs on ThursdayThe data was sourced from BSE at 12.15 am, and the updates from the real-time data could come with a lag. The below data also pertains only...
- Washing powder maker Nirma and Sekhmet vie for $731 million Glenmark Life stake: SourcesNirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-list...
- Weekly breakout scan: Tata Motors DVR, Glenmark Pharma and 8 other stocks crossed last week's highSeveral Indian stocks, including Praj Industries, Granules India, PVR Inox, Mishra Dhatu Nigam, Tata Motors DVR, The Phoenix Mills, Metro B...
- Stock Radar: This pharma company sees breakout after 6-month consolidation; time to buy?Short-term traders can look to buy the stock now or on dips for a possible target of Rs 474 in the next 4-6 weeks, suggested experts
- Glenmark Life’s Rs 1,600-cr issue may open next weekThe initial public offering (IPO) comprises a fresh issue of Rs 1,160 crore and sale of 7.3 million shares by listed promoter Glenmark Phar...
- Utkarsh Small Finance Bank, Glenmark Life Sciences get Sebi's go ahead to float IPOsThe initial public offer (IPO) of Utkarsh Small Finance Bank comprises fresh issue of equity shares worth Rs 750 crore and an offer for sal...
- Glenmark shares hit 52-week low on USFDA warning letterUSFDA had inspected the facility between April 15 and April 20, Glenmark said.
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
Load More
